Metraipolis › archive › dc_b6e8788f044d

Resveratrol in Oral Squamous Cell Carcinoma: Preclinical Evidence and Translational Opportunities — Europe PMC PMID:42358819

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42358819
DOI
10.32604/or.2026.079642
License (as archived)
solo-consultazione
Archived
2026-10-19T09:30:55.416Z
SHA-256 of the archived text
c9305bb7c4627b31e4019260342e06a47f7ff06ddbfccc2b99958626ae03dbf1
Stable URL of this page
https://metraipolis.com/documento/dc_b6e8788f044d

How to cite

Resveratrol in Oral Squamous Cell Carcinoma: Preclinical Evidence and Translational Opportunities — Europe PMC PMID:42358819 — Europe PMC (en), https://europepmc.org/article/MED/42358819 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b6e8788f044d (Metraipolis archive dc_b6e8788f044d, sha256 c9305bb7c4627b31e4019260342e06a47f7ff06ddbfccc2b99958626ae03dbf1)
BibTeX
@misc{dcb6e8788f044d,
  title = {Resveratrol in Oral Squamous Cell Carcinoma: Preclinical Evidence and Translational Opportunities — Europe PMC PMID:42358819},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42358819},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b6e8788f044d; sha256 c9305bb7c4627b31e4019260342e06a47f7ff06ddbfccc2b99958626ae03dbf1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42358819. Agents can read the archived copy with the MCP tool read_document.